Concerning therapeutic strategies aiming at CAFs, it has been reported that the application of inhibitors for STAT3 and MEK1/2 could suppress tumorigenesis in the organotypic model of esophageal cancer [32]. Here, MAP2K1 is linked to esophageal cancer.